Sarah Cannon Research Institute
GPTKB entity
Properties (54)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Research_Institute
|
| gptkbp:affiliatedWith |
gptkb:HCA_Healthcare
|
| gptkbp:collaboratesWith |
Pharmaceutical Companies
|
| gptkbp:focusesOn |
gptkb:Cancer_Research
|
| gptkbp:foundedBy |
gptkb:Sarah_Cannon
|
| gptkbp:hasLocalCuisine |
Targeted Therapies
Biomarker Studies Phase I Trials Phase II Trials Phase III Trials Surgical Techniques Combination Therapies Phase IV Trials Real-world Evidence Studies New Cancer Treatments Long-term Follow-up Studies Radiation Therapy Techniques Immuno-oncology Studies Novel Drug Approaches Patient-reported Outcomes Studies Quality_of_Life_Studies Palliative_Care_Options Health_Economics_Studies Adjuvant_Therapy_Studies Neoadjuvant_Therapy_Studies |
| gptkbp:hasPrograms |
Genomics
Immunotherapy Precision Medicine |
| gptkbp:hasResearchInterest |
gptkb:Lung_Cancer
gptkb:Kidney_Cancer Leukemia Colorectal Cancer Lymphoma Prostate Cancer Pancreatic Cancer Bladder Cancer Breast Cancer Ovarian Cancer Sarcoma Esophageal Cancer Skin Cancer Endometrial Cancer Cervical Cancer Thyroid Cancer Brain Tumors Rare Cancers Head and Neck Cancer Multiple Myeloma Stomach Cancer Neuroendocrine Tumors |
| https://www.w3.org/2000/01/rdf-schema#label |
Sarah Cannon Research Institute
|
| gptkbp:location |
gptkb:Nashville,_Tennessee
|
| gptkbp:offers |
Clinical Trials
|
| gptkbp:provides |
Patient_Care_Services
|